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0929-6441/ª 2014, Elsevier Taiwan LLHypereosinophilic syndrome (HES), or Lo¨effler’s endocarditis, is a heterogenous group of disor-
ders marked by the sustained overproduction of eosinophils involving different organ systems.
Cardiac involvement, recognized as endocardial thickening and left ventricular (LV) mural
thrombi, is the major cause for morbidity and mortality. Herein, we present a case with idio-
pathic HES complicated with severe cardiac involvement, who was treated successfully with
corticosteroids. Echocardiography is pivotal in diagnosis and follow-up.
ª 2014, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine. All rights
reserved.Introduction
Hypereosinophilic syndromes (HES), or Lo¨effler’s endo-
carditis, is characterized by excessive hypereosinophilia
affecting different organ systems. Cardiac involvement, a
major cause of morbidity and mortality, is presented by
endocardial thickening, fibrothrombotic obliteration of the
ventricles and mitral regurgitation (MR) owing to restrictedeclare no conflicts of interest
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C and the Chinese Taipei Societymobility of the posterior mitral leaflet (PML) [1,2]. Multi-
modality imaging, including echocardiography and mag-
netic resonance imaging, are useful in diagnosis and to
detect cardiac fibrosis for risk stratification [3]. Our case
depicted here portrayed a typical cardiac manifestation of
HES, which was later confirmed by endomyocardial biopsy
and treated successfully with corticosteroids. It highlights
the clinical importance of alertness in recognition for
timely treatments.
Case report
A 39-year-old previously healthy gentleman, who worked in
a chemical factory in China, suffered from chronic watery
diarrhea for 9 months; his symptoms deteriorated in theof Ultrasound in Medicine. All rights reserved.
Fig. 1 Severe mitral regurgitation and tricuspid regurgitation (A) diminished after treatment (B). LAZ left atrium; MRZ mitral
regurgitation; RA Z right atrium; TR Z tricuspid regurgitation.
Lo¨effler’s Endocarditis 229past 2 months with a 20 kg body weight loss. The stools
contained no blood, mucus, or membranes. His symptoms
did not alternate with constipation and there was no
abdominal pain, arthralgia, dyspnea, skin rash, or neuro-
logic deficits. He denied animal, insect, and drug exposure.
No similar presentations were identified among his peers.
On examination, his blood pressure was 101/69 mmHg,
pulse rate was 100 beats/minute, temperature was 36.9C,
and his respiration rate was 20 breaths/minute. His body
mass index was 17.1. The abdomen was soft, without
distention or tenderness. Other physical examinations were
unrevealing.
The white cell count was 21,700/mm3 (reference range,
4500e11,000/mm3), with 62% neutrophils (reference range,
40e70%), 4% lymphocytes (reference range, 22e44%), 6%
monocytes (reference range, 4e11%), and 28% eosinophils
(reference range, 0e8%), and the potassium level was 2.7
mEq/L (reference range, 3.5e5 mEq/L). The remainder of
the complete blood count and a urinalysis were normal, as
were results of coagulation and renal- and liver-function
tests, and blood levels of sodium, calcium, phosphorus,Fig. 2 Hypereosinophilic syndrome with cardiac involvement in o
which resolved after corticosteroid treatment (B, arrows). The art
LV Z left ventricle; RV Z right ventricle.magnesium, and glucose. An electrocardiogram (ECG)
showed sinus rhythm and T-wave inversions in leads V2eV6.
Invasive and noninvasive studies (including stool tests,
abdominal ultrasound, computed tomography, esoph-
agogastroduodenoscopy, colonoscopy, small bowel series,
and bone marrow aspiration) failed to delineate a cause for
the chronic diarrhea. Idiopathic HES was diagnosed and
systemic corticosteroid treatment was started.
During admission, an episode of acute pulmonary edema
occurred. Newly found poor R wave progression in anterior
leads on the ECG prompted a subsequent transthoracic
echocardiography (TTE) exam, which showed a dilated left
atrium (diameter, 4.5 cm in the parasternal long axis view),
adequate left ventricular (LV) systolic performance, and
thickenedmitral valvewith restrictedmotion of PML, leading
to severe MR (Fig. 1A) with severe pulmonary hypertension
(estimated pulmonary arterial systolic pressure, 73 mmHg).
Severe tricuspid regurgitation (TR) was also observed
(Fig. 1A). We noted thickening of the LV endocardium, which
was a unique pattern caused by eosinophil infiltration
(Fig. 2A, arrows). The cardiac magnetic resonance (CMR)ur patient was marked by a myocardial thickening (A, arrows),
ifact in the left ventricular apex was also noted (B, asterisk).
Fig. 3 The cardiac magnetic resonance imaging showed subendocardial edema (A, arrows) consistent with areas of first-pass
perfusion defect (B, blue arrows), which appeared in layers in the delayed myocardial enhancement (DME) images. A typical
three-layered appearance consisting of normal myocardium (black, C, D, arrowheads), thickened fibrotic endocardium with in-
flammatory exudate (white, C, D, arrows), and overlying thrombus (black, C, D, asterisk) was displayed in the DME images.
230 L.-T. Yang et al.imaging showed subendocardial edema (Fig. 3A, arrows)
consistent with areas of first-pass perfusion defect (Fig. 3B,
arrows), which was clearly delineated via the delayed
myocardial enhancement (DME) images (Fig. 3C andD). In theFig. 4 The endomyocardial biopsy demonstrated eosinophil
infiltrations (circles).DME images of LV, we saw an innermost layer of hypointense
thrombus and the middle layer of hyperintensity, which was
probably encompassed by inflammatory exudate and fibrotic
tissue (Fig. 3C and D). Combining the image findings, the
endocardial thickening was a result of eosinophil related
myocardium injury and was composed of necrotic tissue,
myocardial fibrosis, and thrombi. A myocardial biopsy of the
right ventricle showed eosinophil infiltration (Fig. 4, circles).
Oral anticoagulant therapy was given to prevent thrombo-
embolic events. Intravenous hydrocortisone (200 mg/day)
was given initially with a gradual taper in dosage and was
shifted to oral prednisolone finally. After treatment with
corticosteroid for 2 months, the follow-up TTE showed a
resolution of endocardial thickening (Fig. 2B), as well as
improvements of MR and TR (Fig. 1B). The peripheral eosin-
ophil count was returned to normal (3.2%, reference range,
0e8%) and his diarrhea also ameliorated.
Discussion
HES is characterized by persistent hypereosinophilia for
at least 6 months without identifiable cause, such as para-
sitic infection, drugs, connective tissue disorders, vasculitis
and malignancies, or allergies [4]. Clinical manifestations
Lo¨effler’s Endocarditis 231include the heart, vascular system, nervous system, and
bone marrow; among them, cardiac involvement, also
known as “Loeffler’s endocarditis”, makes up for approxi-
mately 40e60% and is responsible for most morbidity and
mortality [4,5]. TTE, a valuable diagnostic tool, shows not
only the endocardial thickening, fibrothrombotic oblitera-
tion of the ventricular chamber, and valvular regurgitation,
but also serves as a warning sign of possible myocardial
fibrosis if impaired LV systolic function is identified. CMR
helps to pinpoint myocardial fibrosis in the DME imaging
prior to apparent LV systolic dysfunction and is of prognostic
benefit [3,6]. Indeed, subendocardial fibrosis was disclosed
in our case, albeit the adequacy of global LV systolic per-
formance, which was believed to be the result of inflam-
mation mediated by the cytotoxic substances released from
eosinophils [4]. Meanwhile, CMR provides precise morpho-
logical evaluation and elucidates potential disease mecha-
nisms in HES with cardiac involvement. In the CMR images of
our case, a typical three-layered appearance consisting of
normal myocardium, thickened fibrotic endocardium with
inflammatory exudate, and overlying thrombus were noted
(Fig. 3); this was also mentioned by Syed et al [7].
The gold standard diagnostic tool, however, is endo-
myocardial biopsy. Complications include valvular regurgi-
tation, heart failure, and thromboembolism. Hence, the
treatment goals aim for reduction of peripheral and tissue
eosinophil count to prevent further organ damage and to
prevent embolic events [4]. In our case, aggressive systemic
corticosteroids were used in addition to oral anticoagu-
lants. Fortunately, this patient had good treatment
response. A follow up hemogram showed a remission ofhypereosinophilia; the TTE showed regression of the
endocardial thickening and improved degree of valvular
regurgitation in conjugation with an alleviation in clinical
symptoms.
In conclusion, our case demonstrates the typical cardiac
manifestations in HES. TTE is crucial in diagnosis and serves
as a reflection of treatment response during follow up.References
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